Study of OP-1 Putty in Uninstrumented Posterolateral Fusions

NCT00678353 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 202

Last updated 2011-06-10

No results posted yet for this study

Summary

This study is to provide additional data to support the safety and efficacy of OP-1 Putty as a replacement for autograft in patients undergoing posterolateral spinal fusion.

Conditions

  • Degenerative Lumbar Spondylolisthesis

Sponsors & Collaborators

  • Olympus Biotech Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Completion
2007-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00678353 on ClinicalTrials.gov